Did you mean: eagle investor relations
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class ...
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Program Updates Read More ... Investor Contact. investors@aeglea.
(NASDAQ:AGLE) today announced financial results for the first quarter 2023. ... Annual Report. showing slide 1 of 8. AR 2023 not ... Investor Contact. investors ...
Nov 28, 2023 · (NASDAQ: AGLE) (the "Company" or "Spyre"), a development-stage biotechnology company, today announced its name change to Spyre Therapeutics, Inc ...
People also ask
What happened to Aeglea BioTherapeutics?
Where is Spyre Therapeutics located?
Where is Aeglea BioTherapeutics headquarters?
Who is the CEO of Spyre Therapeutics?
... Investor Relations, telephone number (512) 942-2935. Any stockholders who share the same address and currently receive multiple copies of Aeglea's annual report ...
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Oct 30, 2023 · ... investor conferences: Guggenheim 5th Annual Inflammation & Immunology Conference, New York, New York – November 7th, 2023; Stifel 2023 Annual ...
INVESTORS · Overview · Press releases · Company information · Presentations ... By clicking submit below, I agree to AgEagle's Terms and Conditions and Privacy ...
Missing: agle | Show results with:agle
Nov 9, 2023 · 9, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of ...
AGLE@investorrelations.com. Investor Contact: Joey Perrone. Senior Director, Finance & Investor Relations. Aeglea BioTherapeutics. investors@aegleabio.com.
